A. M. Burger

12.4k total citations
30 papers, 1.2k citations indexed

About

A. M. Burger is a scholar working on Molecular Biology, Oncology and Biotechnology. According to data from OpenAlex, A. M. Burger has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Biotechnology. Recurrent topics in A. M. Burger's work include RNA Interference and Gene Delivery (4 papers), Telomeres, Telomerase, and Senescence (4 papers) and Cancer Research and Treatments (3 papers). A. M. Burger is often cited by papers focused on RNA Interference and Gene Delivery (4 papers), Telomeres, Telomerase, and Senescence (4 papers) and Cancer Research and Treatments (3 papers). A. M. Burger collaborates with scholars based in United States, Germany and United Kingdom. A. M. Burger's co-authors include Heinz‐Herbert Fiebig, Pornima Phatak, John A. Double, David R. Newell, Fangping Dai, M. F. G. STEVENS, Ronald B. Gartenhaus, Victoria Smith, Martin Brandl and Rolf Schubert and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

A. M. Burger

29 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. M. Burger United States 15 799 368 176 158 111 30 1.2k
Melissa Millard United States 14 1.1k 1.4× 298 0.8× 504 2.9× 228 1.4× 132 1.2× 18 1.9k
Shikha Gaur United States 16 487 0.6× 218 0.6× 59 0.3× 206 1.3× 86 0.8× 28 875
Federico Carafoli United Kingdom 14 552 0.7× 216 0.6× 114 0.6× 184 1.2× 50 0.5× 14 1.3k
Sandra Galoforo United States 16 721 0.9× 196 0.5× 94 0.5× 261 1.7× 59 0.5× 35 1.1k
Alessandra Tuccitto Italy 8 597 0.7× 312 0.8× 145 0.8× 228 1.4× 42 0.4× 9 1.1k
Prakash Radhakrishnan United States 21 986 1.2× 549 1.5× 173 1.0× 429 2.7× 92 0.8× 47 1.7k
Vadim S. Pokrovsky Russia 21 646 0.8× 128 0.3× 97 0.6× 171 1.1× 288 2.6× 111 1.2k
Gennadi V. Glinsky United States 18 1.3k 1.6× 593 1.6× 96 0.5× 261 1.7× 158 1.4× 22 1.9k
Sung‐Gil Chi South Korea 19 732 0.9× 234 0.6× 41 0.2× 214 1.4× 55 0.5× 32 1.1k
Amor Hajri France 19 378 0.5× 346 0.9× 50 0.3× 138 0.9× 135 1.2× 34 1.0k

Countries citing papers authored by A. M. Burger

Since Specialization
Citations

This map shows the geographic impact of A. M. Burger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. M. Burger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. M. Burger more than expected).

Fields of papers citing papers by A. M. Burger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. M. Burger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. M. Burger. The network helps show where A. M. Burger may publish in the future.

Co-authorship network of co-authors of A. M. Burger

This figure shows the co-authorship network connecting the top 25 collaborators of A. M. Burger. A scholar is included among the top collaborators of A. M. Burger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. M. Burger. A. M. Burger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rabie, Mohamed, et al.. (2019). The effect of Oncotype DX® on adjuvant chemotherapy treatment decisions in early breast cancer. Annals of The Royal College of Surgeons of England. 101(8). 596–601. 4 indexed citations
2.
Nakanishi, Takeo, Saranya Chumsri, Nazanin Khakpour, et al.. (2010). Side-population cells in luminal-type breast cancer have tumour-initiating cell properties, and are regulated by HER2 expression and signalling. British Journal of Cancer. 102(5). 815–826. 77 indexed citations
3.
Linn, Douglas E., Feng Sun, Yuancai Xie, et al.. (2010). A Role for OCT4 in Tumor Initiation of Drug-Resistant Prostate Cancer Cells. Genes & Cancer. 1(9). 908–916. 83 indexed citations
4.
Dai, Fangping, et al.. (2009). Telomerase Activity and Telomere Length in Human Tumor Cells with Acquired Resistance to Anticancer Agents. Journal of Chemotherapy. 21(5). 542–549. 13 indexed citations
5.
Goloubeva, Olga, James Zweibel, James R. Wright, et al.. (2008). Phase I trial of vorinostat plus bortezomib (bort) in relapsed/refractory multiple myeloma (mm) patients (pts). Journal of Clinical Oncology. 26(15_suppl). 8548–8548. 17 indexed citations
6.
Phatak, Pornima & A. M. Burger. (2007). Telomerase and its potential for therapeutic intervention. British Journal of Pharmacology. 152(7). 1003–1011. 71 indexed citations
7.
Burger, A. M., Paul M. Loadman, David E. Thurston, et al.. (2007). Preclinical Pharmacology of the Pyrrolobenzodiazepine (PBD) Monomer DRH-417 (NSC 709119). Journal of Chemotherapy. 19(1). 66–78. 13 indexed citations
8.
Badros, Ashraf, Rubén Niesvizky, Olga Goloubeva, et al.. (2007). Phase I Trial of Suberoylanilide Hydroxamic Acid (SAHA) + Bortezomib (Bort) in Relapsed Multiple Myeloma (MM) Patients (pts).. Blood. 110(11). 1168–1168. 22 indexed citations
9.
Phatak, Pornima, Fangping Dai, Victoria Smith, et al.. (2007). Telomere uncapping by the G-quadruplex ligand RHPS4 inhibits clonogenic tumour cell growth in vitro and in vivo consistent with a cancer stem cell targeting mechanism. British Journal of Cancer. 96(8). 1223–1233. 152 indexed citations
10.
Fiebig, Heinz‐Herbert, et al.. (2004). Clonogenic assay with established human tumour xenografts. European Journal of Cancer. 40(6). 802–820. 224 indexed citations
11.
Wong, Michael, A. Richard Kitching, Liliana Attisano, et al.. (2003). The RING-H2 protein RNF11 is overexpressed in breast cancer and is a target of Smurf2 E3 ligase. British Journal of Cancer. 89(8). 1538–1544. 77 indexed citations
12.
Massing, Ulrich, et al.. (2003). 5-Fluorouracil in vesicular phospholipid gels for anticancer treatment: entrapment and release properties. International Journal of Pharmaceutics. 256(1-2). 123–131. 87 indexed citations
13.
Moog, Rainer, A. M. Burger, Martin Brandl, et al.. (2002). Change in pharmacokinetic and pharmacodynamic behavior of gemcitabine in human tumor xenografts upon entrapment in vesicular phospholipid gels. Cancer Chemotherapy and Pharmacology. 49(5). 356–366. 72 indexed citations
14.
Burger, A. M., Hans R. Hendriks, H. Zwierzina, & H.H. Fiebig. (2001). Enhanced antitumor activity of anti-VEGF antibody HuMV833 in combination with gemcitabine in human pancreatic and renal tumor xenografts. European Journal of Cancer. 37. S105–S105. 1 indexed citations
15.
Wilhelm-Ogunbiyi, Karin, Babette Möckel, A. M. Burger, et al.. (2001). rViscumin, a novel anticancer agent — preclinical and clinical development status. European Journal of Cancer. 37. S5–S5. 2 indexed citations
16.
Burger, A. M., et al.. (1998). Detection of novel genes that are up-regulated (Di12) or down-regulated (T1A12) with disease progression in breast cancer. European Journal of Cancer Prevention. 7. S29–S36. 13 indexed citations
17.
Burger, A. M., Heinz‐Herbert Fiebig, Michael Kuettel, et al.. (1998). Effect of oncogene expression on telomerase activation and telomere length in human endothelial, fibroblast and prostate epithelial cells.. International Journal of Oncology. 13(5). 1043–8. 21 indexed citations
18.
Burger, A. M., John A. Double, & David R. Newell. (1997). Inhibition of telomerase activity by cisplatin in human testicular cancer cells. European Journal of Cancer. 33(4). 638–644. 129 indexed citations
19.
Burger, A. M., et al.. (1996). Identification of differentially expressed genes in breast cancer. International Journal of Oncology. 8(2). 395–400. 7 indexed citations
20.
Burger, A. M., Gurmeet Kaur, Michael C. Alley, et al.. (1995). Tyrphostin AG17, [(3,5-Di-tert-butyl-4-hydroxybenzylidene)- malononitrile], inhibits cell growth by disrupting mitochondria.. PubMed. 55(13). 2794–9. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melissa Millard Breakdown of academic impact, for papers by Shikha Gaur Breakdown of academic impact, for papers by Federico Carafoli Breakdown of academic impact, for papers by Sandra Galoforo Breakdown of academic impact, for papers by Alessandra Tuccitto Breakdown of academic impact, for papers by Prakash Radhakrishnan Breakdown of academic impact, for papers by Vadim S. Pokrovsky Breakdown of academic impact, for papers by Gennadi V. Glinsky Breakdown of academic impact, for papers by Sung‐Gil Chi Breakdown of academic impact, for papers by Amor Hajri
Rankless by CCL
2026